Welcome, this website is intended for all international healthcare professionals in uro-oncology. By clicking the link below you are declaring and confirming that you are a healthcare professional.

You are here

Interview with Prof. Mark Babjuk - EAU guidelines for non muscle invasive bladder cancer (NMIBC)

EAU guidelines for non muscle invasive bladder cancer (NMIBC) Prof. Babjuk

Professor Marek Babjuk MD
Department of Urology, Hospital Motol
Second Faculty of Medicine,  Charles University, Prague, Czech Republic

Video transcript:
I am Marco Babjuk.  I am coming from Prague, from Czech Republic, and in EAU I am particularly involved in the guidelines of non-muscle invasive bladder cancer, and this also was the topic of the session where I participated today.  We had a debate about the treatment of patients with high risk non-muscle invasive bladder cancer, with T1 Grade 3 tumour, and my task was to specify the position of trans-vitro surgery and the trans-vitro resection how it should be done, how can we do it better than we did in last years and so on.

I think endoscopic surgery for bladder cancer is the traditional treatment that we performed for many years, but in the last years appeared a lot of new devices, new approaches which I hope will in the future will bring better clinical results, or I hope it will bring already today, but I hope it will improve in the future.

We spoke about the new method of visualisation of the tumour, like for instance, endoscopy, like ?Merrill-bent imaging or SPIES, I mean the method which can help us to detect really all tumour lesions.  I spoke about how they can help us to remove really all tumours.  And the second point, main point of my lecture was the strategy or technique resection, the technique of tumour removal because we developed in last years some strategy or technique of unblock resection when we try to remove the whole tumour, unblock in total, so it means not to cut inside the tumour which helps us to achieve the resection or surgery of high quality, and particularly we also achieve a good specimen for pathological investigation so we can get more information from our pathologists.

Today we have some new devices which I used for so-called 'device assisted installation' when we make intravesical installation of tumour therapy by which we try to improve its efficacy, for instance by thermal heating of the bladder, and so on.

I think the main take-home message is that we should try to do our job even better than we did in last years.  We try to develop that and we should really consider each individual point that we are going to get diagnosis and treatment and try to improve that.  This is I think the main message, but it is connected with all activities of the EAU.

Video summary:
EAU recently released guidelines on non-muscle invasive bladder cancer (NMIBC) which were discussed at the EAU 2017 Congress. The guidelines committee was headed by Prof. Marek Babjuk and this video features him talking about the salient points of the EAU guidelines especially the position of transurethral surgery. He highlights the importance of the surgical techniques such as en bloc resection (EBR) to remove tumours in bladder cancer. He also stresses on the advantages of EBR in terms of not only achieving a high quality surgery but also obtaining a high quality sample for pathological investigation of the tumour.